BLFS
Price
$24.88
Change
-$1.99 (-7.41%)
Updated
Dec 18, 04:59 PM (EDT)
85 days until earnings call
HAE
Price
$78.75
Change
-$3.32 (-4.05%)
Updated
Dec 18, 04:59 PM (EDT)
55 days until earnings call
Ad is loading...

BLFS vs HAE

Header iconBLFS vs HAE Comparison
Open Charts BLFS vs HAEBanner chart's image
BioLife Solutions
Price$24.88
Change-$1.99 (-7.41%)
Volume$18.5K
CapitalizationN/A
Haemonetics
Price$78.75
Change-$3.32 (-4.05%)
Volume$7.25K
CapitalizationN/A
BLFS vs HAE Comparison Chart
Loading...
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HAE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BLFS vs. HAE commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLFS is a Hold and HAE is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (BLFS: $26.87 vs. HAE: $82.07)
Brand notoriety: BLFS and HAE are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BLFS: 79% vs. HAE: 61%
Market capitalization -- BLFS: $810.87M vs. HAE: $4.33B
BLFS [@Medical Specialties] is valued at $810.87M. HAE’s [@Medical Specialties] market capitalization is $4.33B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLFS’s FA Score shows that 1 FA rating(s) are green whileHAE’s FA Score has 0 green FA rating(s).

  • BLFS’s FA Score: 1 green, 4 red.
  • HAE’s FA Score: 0 green, 5 red.
According to our system of comparison, BLFS is a better buy in the long-term than HAE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLFS’s TA Score shows that 7 TA indicator(s) are bullish while HAE’s TA Score has 3 bullish TA indicator(s).

  • BLFS’s TA Score: 7 bullish, 2 bearish.
  • HAE’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, BLFS is a better buy in the short-term than HAE.

Price Growth

BLFS (@Medical Specialties) experienced а +2.56% price change this week, while HAE (@Medical Specialties) price change was -2.16% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.17%. For the same industry, the average monthly price growth was +1.60%, and the average quarterly price growth was -0.66%.

Reported Earning Dates

BLFS is expected to report earnings on Mar 13, 2025.

HAE is expected to report earnings on Feb 11, 2025.

Industries' Descriptions

@Medical Specialties (-4.17% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HAE($4.34B) has a higher market cap than BLFS($811M). BLFS has higher P/E ratio than HAE: BLFS (238.10) vs HAE (34.47). BLFS YTD gains are higher at: 65.354 vs. HAE (-4.023). HAE has higher annual earnings (EBITDA): 264M vs. BLFS (-45.24M). HAE has more cash in the bank: 194M vs. BLFS (51.7M). BLFS has less debt than HAE: BLFS (42.7M) vs HAE (871M). HAE has higher revenues than BLFS: HAE (1.27B) vs BLFS (143M).
BLFSHAEBLFS / HAE
Capitalization811M4.34B19%
EBITDA-45.24M264M-17%
Gain YTD65.354-4.023-1,625%
P/E Ratio238.1034.47691%
Revenue143M1.27B11%
Total Cash51.7M194M27%
Total Debt42.7M871M5%
FUNDAMENTALS RATINGS
BLFS vs HAE: Fundamental Ratings
BLFS
HAE
OUTLOOK RATING
1..100
7869
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
75
Overvalued
PROFIT vs RISK RATING
1..100
77100
SMR RATING
1..100
9358
PRICE GROWTH RATING
1..100
3759
P/E GROWTH RATING
1..100
1539
SEASONALITY SCORE
1..100
2n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HAE's Valuation (75) in the Medical Specialties industry is in the same range as BLFS (95). This means that HAE’s stock grew similarly to BLFS’s over the last 12 months.

BLFS's Profit vs Risk Rating (77) in the Medical Specialties industry is in the same range as HAE (100). This means that BLFS’s stock grew similarly to HAE’s over the last 12 months.

HAE's SMR Rating (58) in the Medical Specialties industry is somewhat better than the same rating for BLFS (93). This means that HAE’s stock grew somewhat faster than BLFS’s over the last 12 months.

BLFS's Price Growth Rating (37) in the Medical Specialties industry is in the same range as HAE (59). This means that BLFS’s stock grew similarly to HAE’s over the last 12 months.

BLFS's P/E Growth Rating (15) in the Medical Specialties industry is in the same range as HAE (39). This means that BLFS’s stock grew similarly to HAE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BLFSHAE
RSI
ODDS (%)
Bullish Trend 2 days ago
57%
Bearish Trend 2 days ago
63%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
76%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
70%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
66%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
60%
Advances
ODDS (%)
Bullish Trend 7 days ago
80%
Bullish Trend 9 days ago
68%
Declines
ODDS (%)
Bearish Trend 14 days ago
84%
Bearish Trend 6 days ago
63%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
71%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
51%
View a ticker or compare two or three
Ad is loading...
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HAE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ERBAX19.45N/A
N/A
Eaton Vance Richard Bernstein Eq Strat A
JOGEX12.11N/A
N/A
JOHCM Global Select Advisor
DIFFX12.25-0.02
-0.16%
MFS Diversified Income R3
CIISX15.16-0.07
-0.46%
Causeway International Small Cap Instl
HGISX56.46-0.27
-0.48%
Hartford Core Equity R4

BLFS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLFS has been loosely correlated with AZTA. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if BLFS jumps, then AZTA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLFS
1D Price
Change %
BLFS100%
-1.83%
AZTA - BLFS
54%
Loosely correlated
+4.09%
MASS - BLFS
49%
Loosely correlated
-5.58%
RGEN - BLFS
49%
Loosely correlated
-1.73%
VCYT - BLFS
49%
Loosely correlated
-2.52%
FLGT - BLFS
43%
Loosely correlated
-1.12%
More

HAE and

Correlation & Price change

A.I.dvisor indicates that over the last year, HAE has been loosely correlated with OM. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if HAE jumps, then OM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HAE
1D Price
Change %
HAE100%
-0.22%
OM - HAE
41%
Loosely correlated
-4.72%
GH - HAE
39%
Loosely correlated
-2.19%
CRL - HAE
32%
Poorly correlated
-0.39%
A - HAE
31%
Poorly correlated
-0.88%
BLFS - HAE
30%
Poorly correlated
-1.83%
More